NICE has recommended givinostat for all DMD types, offering around 530 patients a drug that may delay disease progression by up to 5 years.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/nice-recommends-givinostat-duchenne-muscular-dystrophy-2026a1000evj?src=rss
Author :
Publish date : 2026-05-08 14:38:00
Copyright for syndicated content belongs to the linked Source.
